+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

FEMALE
ID06276309

Study of Protein Features and Outcomes in Women With Cervical Neuroendocrine Tumors

Led by Fujian Maternity and Child Health Hospital · Updated on 2024-09-19

300

Participants Needed

9

Research Sites

8 weeks

Total Duration

AI-Summary

What this Trial Is About

Researchers are studying cervical neuroendocrine tumors by collecting clinical diagnosis and treatment data from 300 patients. This includes information like age, biopsy results, histopathology, and follow-up survival data. The goal is to analyze the molecular characteristics and prognosis of this cancer type to better understand its behavior and potential clinical applications. The study also gathers paraffin tissue samples from 100 cases across multiple centers to perform protein concentration and omics analyses. These tests help establish molecular features and identify prognostic markers of cervical neuroendocrine tumors. Participants medical and follow-up data are reviewed to assess outcomes such as mortality rate and disease-free survival within three years after surgery. The study builds a database to support ongoing research and analysis of cervical neuroendocrine tumors protein profiles and patient prognosis.

CONDITIONS

Brief Title

Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors

Research Team

B

Binhua Dong

P

Pengming Sun

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here